Mr. Speaker, my constituents in Nanaimo—Ladysmith are having an increasingly difficult time paying the rising costs of pharmaceutical drugs. It is clear that it is beyond time to implement a universal pharmacare program. The new NAFTA includes provisions that extend patents on drugs from eight years to 10 years and will keep the cost of drugs high for consumers longer. What is the government prepared to do to keep pharmaceuticals affordable for those who need them, and to stop the excessive profiteering of big pharma?
In the House of Commons on June 4th, 2019. See this statement in context.